Dr. Deutsch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
801 N Flamingo Rd
Ste 11
Hollywood, FL 33028Phone+1 954-265-4325Fax+1 954-981-3872- Is this information wrong?
Education & Training
University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 2012 - 2015- University of Miami/Jackson Health SystemResidency, Internal Medicine, 2009 - 2012
University of Miami Leonard M. Miller School of MedicineClass of 2009
Certifications & Licensure
FL State Medical License 2015 - 2025- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Mutations highly specific for secondary AML are associated with poor outcomes in ELN favorable risk NPM1-mutated AML.Onyee Chan, Najla Al Ali, Hammad Tashkandi, Austin Ellis, Somedeb Ball, Justin Grenet, Caroline Hana, Yehuda Deutsch, Ling Zhang, Mohammad Hussaini, Jinming Song, Seon...> ;Blood Advances. 2024 Mar 12
- 6 citationsMolecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutations.Somedeb Ball, Todd C Knepper, Yehuda E Deutsch, Wassim Samra, Justin M Watts, Terrence J Bradley, Onyee Chan, Mohammad Omar Hussaini, Ling Zhang, Kendra L Sweet, Andre...> ;Cancer. 2022 Nov 1
- 5 citationsCPX-351 Yields Similar Response and Survival Outcome in Younger and Older Patients With Secondary Acute Myeloid Leukemia.Dasom Lee, Akriti G Jain, Yehuda Deutsch, Jennifer Eatrides, Onyee Chan, Eric Padron, Andrew Kuykendall, Rami Komrokji, Jeffrey Lancet, David Sallman, Chetasi Talati, ...> ;Clinical Lymphoma, Myeloma & Leukemia. 2022 Oct 1
- Join now to see all
Abstracts/Posters
- Outcomes of Patients with Relapsed or Refractory Acute Myeloid Leukemia Receiving Hypomethylating Agent and VenetoclaxYehuda E. Deutsch, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Hypomethylating Agent and Venetoclax Combination Yields Comparable Outcomes to CPX-351 in Newly Diagnosed Acute Myeloid LeukemiaYehuda E. Deutsch, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Hypomethylating Agent and Venetoclax Combination Therapy Yields Superior Outcomes When Compared to Hypomethylating Agent Monotherapy in Patients _70 Years with Acute M...Yehuda E. Deutsch, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- Safety and Efficacy of Midostaurin in Combination with High-Dose Daunorubicin in 7+3 Induction for Acute Myeloid Leukemia with FLT3 Mutation61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Increased Frequency of IDH1/2 Mutations in Extramedullary Acute Myeloid Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Leukemia, Infertility Survivor Shares Story of Faith & HopeMarch 8th, 2017
Hospital Affiliations
Jackson Health SystemMiami, Florida
University of Miami HospitalMiami, Florida
Miami Veterans Affairs Healthcare SystemMiami, Florida
UMHC-Sylvester Comprehensive Cancer CenterMiami, Florida
H. Lee Moffitt Cancer Center and Research InstituteTampa, Florida
Memorial Hospital WestPembroke Pines, Florida
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
